CONTIN, MANUELA MARIA ANTONIA
 Distribuzione geografica
Continente #
NA - Nord America 5.146
AS - Asia 3.295
EU - Europa 2.673
SA - Sud America 212
AF - Africa 188
Continente sconosciuto - Info sul continente non disponibili 167
OC - Oceania 7
Totale 11.688
Nazione #
US - Stati Uniti d'America 5.059
SG - Singapore 905
VN - Vietnam 799
CN - Cina 745
IT - Italia 669
GB - Regno Unito 525
DE - Germania 332
HK - Hong Kong 307
SE - Svezia 288
IN - India 165
BR - Brasile 145
RU - Federazione Russa 132
FR - Francia 131
UA - Ucraina 125
NL - Olanda 116
IE - Irlanda 103
BD - Bangladesh 66
JP - Giappone 62
KR - Corea 57
FI - Finlandia 50
CI - Costa d'Avorio 48
ZA - Sudafrica 48
CA - Canada 46
TG - Togo 41
EE - Estonia 38
JO - Giordania 37
AR - Argentina 34
BG - Bulgaria 32
CH - Svizzera 30
PH - Filippine 23
BE - Belgio 22
SC - Seychelles 22
TH - Thailandia 21
ES - Italia 16
ID - Indonesia 16
PL - Polonia 14
MX - Messico 13
TW - Taiwan 13
AT - Austria 11
TR - Turchia 11
MY - Malesia 10
SA - Arabia Saudita 9
HR - Croazia 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
NG - Nigeria 7
PK - Pakistan 7
VE - Venezuela 7
CL - Cile 5
MA - Marocco 5
PE - Perù 5
RS - Serbia 5
AU - Australia 4
DK - Danimarca 4
DZ - Algeria 4
EC - Ecuador 4
GR - Grecia 4
GT - Guatemala 4
IQ - Iraq 4
JM - Giamaica 4
NI - Nicaragua 4
RO - Romania 4
BB - Barbados 3
CY - Cipro 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
PY - Paraguay 3
AZ - Azerbaigian 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
GP - Guadalupe 2
IR - Iran 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
MG - Madagascar 1
Totale 11.514
Città #
Singapore 608
Ashburn 495
Southend 426
Chandler 333
San Jose 331
Ann Arbor 318
Fairfield 310
Hong Kong 284
Houston 180
Hanoi 174
Ho Chi Minh City 174
Santa Clara 170
Woodbridge 158
Seattle 147
Council Bluffs 145
Bologna 136
Princeton 127
Wilmington 125
Hefei 116
Cambridge 115
Beijing 107
Dublin 103
Boardman 97
Los Angeles 88
Jacksonville 80
New York 58
Dallas 57
Lauterbourg 53
Milan 51
Turin 51
Abidjan 48
Redmond 48
Tokyo 48
Seoul 44
Westminster 43
Lomé 41
Buffalo 40
Helsinki 40
Nanjing 40
Amman 37
Padova 36
Frankfurt am Main 35
Berlin 33
Sofia 31
Chicago 30
Florence 30
Haiphong 27
São Paulo 27
Shanghai 25
Dong Ket 24
Bern 23
Jinan 21
Saint Petersburg 21
Bremen 20
Brussels 20
Redondo Beach 20
Phoenix 19
Orem 18
Rome 18
Da Nang 17
Dearborn 17
San Diego 16
Shenyang 16
The Dalles 16
Toronto 16
Atlanta 15
Bengaluru 15
Guangzhou 15
Jiaxing 13
Warsaw 13
Changsha 12
Medford 12
Nuremberg 12
Tianjin 12
Brooklyn 11
Des Moines 11
Johannesburg 11
Mülheim 11
Bangkok 10
Biên Hòa 10
Hangzhou 10
London 10
Munich 10
Naples 10
Redwood City 10
San Francisco 10
Amsterdam 9
Bến Tre 9
Chennai 9
Hebei 9
Hải Dương 9
Jakarta 9
Mahé 9
Modena 9
Montreal 9
Thái Nguyên 9
Can Tho 8
Cesena 8
Denver 8
Fuzhou 8
Totale 6.987
Nome #
Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy 434
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 371
Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy 303
The effect of a clinically practical exercise on levodopa bioavailability and motor response in patients with Parkinson disease. 286
DNMT1 mutations leading to neurodegeneration paradoxically reflect on mitochondrial metabolism 281
Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease. 280
Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. 273
Supervised versus unsupervised technology-based levodopa monitoring in Parkinson’s disease: an intrasubject comparison 258
Mathematical modeling and parameter estimation of levodopa motor response in patients with Parkinson disease 241
Volumetric absorptive microsampling coupled with UHPLC-MS/MS for the determination of Lyso-Gb3 as Fabry disease diagnostic biomarker 237
Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications 228
Apparecchiatura per l'esecuzione di test psicomotori. 223
A longitudinal study of a family with adult-onset autosomal dominant leukodystrophy: Clinical, autonomic and neuropsychological findings 222
Effect of valproic acid on perampanel pharmacokinetics in patients with epilepsy. 222
Dyskinesia detection and monitoring by a single sensor in patients with Parkinson's disease 219
Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy 209
Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue? 208
Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease 205
Relationship between plasma concentrations and clinical effects of perampanel: A prospective observational study 201
Sex Is the Main Determinant of Levodopa Clinical Pharmacokinetics: Evidence from a Large Series of Levodopa Therapeutic Monitoring 199
Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. 199
Mucuna pruriens in Parkinson Disease: A Kinetic-Dynamic Comparison With Levodopa Standard Formulations 199
A mathematical model of levodopa medication effect on basal ganglia in parkinson’s disease: An application to the alternate finger tapping task 199
Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophy. 197
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship 195
Interazione farmacologica tra ACTH e trattamento antiepilettico: descrizione di un caso clinico 193
Variation in Lamotrigine Plasma Concentrations with Hormonal Contraceptive Monthly Cycles in Patients with Epilepsy 186
Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy. 182
Daytime sympathetic hyperactivity in OSAS is related to excessive daytime sleepiness. 181
Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease. 179
Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy 177
Interazione farmacologica tra ACTH e trattamento antiepilettico: descrizione di un caso clinico 176
A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia 174
Liver transplant reverses biochemical imbalance in mitochondrial neurogastrointestinal encephalomyopathy 169
Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy. 168
The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease. 166
Iodine-123-meta-iodobenzylguanidine myocardial scintigraphy in isolated autonomic failure: Potential red flag for future multiple system atrophy 166
CPAP treatment lowers sympathetic nerve activity and blood pressure in hypertensive obstructive sleep apnoea patients. 164
Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias. 158
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 158
Interazione farmacologica tra ACTH e trattamento antiepilettico: descrizione di un caso clinico 153
Il monitoraggio terapeutico dei farmaci antiepilettici 153
Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson’s disease 151
Assessing dopaminergic function in early onset Parkinson's disease linked to homozygous PINK1 mutation. 150
Il trattamento con CPAP riduce l'attività simpatica e la pressione arteriosa in pazienti con Sindrome delle Apnee Ostruttive nel Sonno ed ipertensione. 147
A rapid and simple uhplc-ms/ms method for quantification of plasma globotriaosylsphingosine (Lyso-gb3) 146
Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset 146
Polisomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless legs syndrome. 138
HPLC-UV analysis of thymidine and deoxyuridine in plasma of patients with thymidine phosphorylase deficiency 138
Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy. 132
Development and validation of volumetric absorptive microsampling coupled with UHPLC-MS/MS for the analysis of gamma-hydroxybutyric acid in human blood 132
Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list 128
Intrasubject reproducibility of supine norepinephrine plasma concentrations in patients with cardiovascular sympathetic failure 126
Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome 117
Quantitative Assessment of Motor Response to a Low Subacute Levodopa Dose in the Differential Diagnosis of Parkinsonisms at Disease Onset: Data from the BoProPark Cohort 115
Il monitoraggio terapeutico dei farmaci in neurologia 114
Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey 112
TELEmedicine for EPIlepsy Care (TELE-EPIC): Protocol of a randomised, open controlled non-inferiority clinical trial 111
TYMP Variants Result in Late-Onset Mitochondrial Myopathy With Altered Muscle Mitochondrial DNA Homeostasis 105
Screening for impulse control disorders in Parkinson's disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors 98
Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam 78
Autonomic failure in a case of Chiari malformation type I 73
Cerebrospinal Fluid Concentrations of Nimodipine Correlate With Long-term Outcome in Aneurysmal Subarachnoid Hemorrhage: Pilot Study 70
Isolated failure of noradrenergic transmission in a case with orthostatic hypotension and hyperactivity of gastro-colic reflex 51
Autonomic nervous system function in myotonic dystrophy 43
Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitone 41
Severe dysautonomic onset of Guillain-Barré syndrome with good recovery. A clinical and autonomic follow-up study 34
Totale 11.688
Categoria #
all - tutte 31.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.904


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.097 0 0 0 92 104 70 40 100 82 123 255 231
2022/20231.335 140 198 72 152 81 98 50 75 241 25 131 72
2023/2024431 23 66 32 41 42 89 24 21 28 25 10 30
2024/20251.409 65 186 138 96 252 71 87 35 14 120 49 296
2025/20263.607 319 292 277 292 432 210 423 131 709 245 132 145
2026/20271.092 189 372 281 250 0 0 0 0 0 0 0 0
Totale 11.688